{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:49:54Z","timestamp":1770752994401,"version":"3.50.0"},"reference-count":42,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2003,1,1]]},"abstract":"<jats:p>Objective. To evaluate a secondary liver iron overload and its fate in children who are treated conventionally for acute lymphoblastic leukemia and to assess whether serum soluble transferrin receptor (sTfR) is useful in detecting iron load.<\/jats:p>\n               <jats:p>Methods. Liver siderosis was estimated histologically from liver biopsy specimens of 30 children (aged 2.6\u201317.6 years) close to or at the end of therapy using total iron score (TIS). Serum iron parameters and sTfR were measured at the same time and in 22 patients 1 to 3 years after therapy.<\/jats:p>\n               <jats:p>Results. In 19 (63%) of 30 patients, liver TIS was &amp;gt;15, indicating at least moderate iron overload. Serum ferritin, iron, and transferrin iron saturation levels were highest and transferrin level lowest in the patients with the highest liver iron content. Serum sTfR levels did not differ significantly between the patients with varying amounts of liver iron. TIS correlated most significantly positively with serum ferritin (rS = 0.899), transferrin iron saturation (rS = 0.764), and the amount of transfused red blood cells (rS = 0.783). Serum iron parameters normalized in most patients during the follow-up. In 3 (14%) of 22 patients, serum ferritin level remained high (&amp;gt;1000 \u03bcg\/L).<\/jats:p>\n               <jats:p>Conclusions. Long-term iron overload is detected in at least 14% of children after therapy for acute lymphoblastic leukemia. Serum sTfR is an inappropriate marker for liver iron overload, whereas ferritin seems to be the most useful serologic marker for it.<\/jats:p>","DOI":"10.1542\/peds.111.1.91","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:43:47Z","timestamp":1092444227000},"page":"91-96","source":"Crossref","is-referenced-by-count":50,"title":["Iron Overload in Children Who Are Treated for Acute Lymphoblastic Leukemia Estimated by Liver Siderosis and Serum Iron Parameters"],"prefix":"10.1542","volume":"111","author":[{"given":"Pa\u0308ivi","family":"Halonen","sequence":"first","affiliation":[{"name":"Paediatric Research Centre, Medical School, University of Tampere, Tampere, Finland"},{"name":"Departments of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorma","family":"Mattila","sequence":"additional","affiliation":[{"name":"Pathology, Tampere University Hospital, Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauli","family":"Suominen","sequence":"additional","affiliation":[{"name":"Turku University Central Hospital Laboratories Unit, Turku University Central Hospital, Turku, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarja","family":"Ruuska","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti K.","family":"Salo","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Ma\u0308kipernaa","sequence":"additional","affiliation":[{"name":"Finnish Red Cross Blood Transfusion Service, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2003,1,1]]},"reference":[{"key":"2021120821081957100_R1","doi-asserted-by":"crossref","unstructured":"Armitage JO, Burns CP, Kent TH. Liver disease complicating the management of acute leukemia during remission. Cancer.1978;41:737\u2013742","DOI":"10.1002\/1097-0142(197802)41:2<737::AID-CNCR2820410246>3.0.CO;2-7"},{"key":"2021120821081957100_R2","doi-asserted-by":"crossref","unstructured":"Parker D, Bate CM, Craft AW, Graham-Pole J, Malpas JS, Stansfeld AG. Liver damage in children with acute leukaemia and non-Hodgkin\u2019s lymphoma on oral maintenance chemotherapy. Cancer Chemother Pharmacol.1980;4:121\u2013127","DOI":"10.1007\/BF00254033"},{"key":"2021120821081957100_R3","doi-asserted-by":"crossref","unstructured":"Topley JM, Benson J, Squier MV, Chessells JM. Hepatotoxicity in the treatment of acute lymphoblastic leukaemia. Med Pediatr Oncol.1979;7:393\u2013399","DOI":"10.1002\/mpo.2950070415"},{"key":"2021120821081957100_R4","doi-asserted-by":"crossref","unstructured":"Locasciulli A, Vergani GM, Underzo C, et al. Chronic liver disease in children with leukemia in long-term remission. Cancer.1983;52:1080\u20131087","DOI":"10.1002\/1097-0142(19830915)52:6<1080::AID-CNCR2820520625>3.0.CO;2-K"},{"key":"2021120821081957100_R5","doi-asserted-by":"crossref","unstructured":"Guido M, Rossetti F, Rugge M, et al. Leukemia and liver disease in childhood: clinical and histological evaluation. Tumori.1991;77:319\u2013322","DOI":"10.1177\/030089169107700405"},{"key":"2021120821081957100_R6","unstructured":"Colsky J, Greenspan EM, Warren TN. Hepatic fibrosis in children with acute lymphoblastic leukaemia after therapy with folic acid antagonists. Arch Pathol Lab Med.1955;59:198\u2013206"},{"key":"2021120821081957100_R7","doi-asserted-by":"crossref","unstructured":"Nesbit M, Krivit W, Heyn R, Sharp H. Acute and chronic effects of methotrexate on hepatic, pulmonary and skeletal system. Cancer.1976;37(suppl 2):1048\u20131054","DOI":"10.1002\/1097-0142(197602)37:2+<1048::AID-CNCR2820370811>3.0.CO;2-V"},{"key":"2021120821081957100_R8","doi-asserted-by":"crossref","unstructured":"McIntosh S, Davidson DL, O\u2019Brien RT, Pearson HL. Methotrexate hepatotoxicity in children with leukemia. J Pediatr.1977;90:1019\u20131021","DOI":"10.1016\/S0022-3476(77)80587-8"},{"key":"2021120821081957100_R9","unstructured":"Perry MC. Chemotherapeutic agents and hepatotoxicity. Semin Oncol.1992;19:551\u2013565"},{"key":"2021120821081957100_R10","doi-asserted-by":"crossref","unstructured":"King PD, Perry MC. Hepatotoxicity of chemotherapeutic and oncologic agents. Gastroenterol Clin North Am.1995;24:969\u2013990","DOI":"10.1016\/S0889-8553(21)00236-3"},{"key":"2021120821081957100_R11","doi-asserted-by":"crossref","unstructured":"Locasciulli A, Gornati G, Tagger A, et al. Hepatitis C virus infection and chronic liver disease in children with leukemia in long term remission. Blood.1991;78:1619\u20131622","DOI":"10.1182\/blood.V78.6.1619.1619"},{"key":"2021120821081957100_R12","doi-asserted-by":"crossref","unstructured":"Arico M, Maggiore G, Silini E, et al. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood.1994;84:2919\u20132922","DOI":"10.1182\/blood.V84.9.2919.bloodjournal8492919"},{"key":"2021120821081957100_R13","doi-asserted-by":"crossref","unstructured":"Malone W, Novak R. Outcome of hepatitis in children with acute leukemia. Am J Dis Child.1980;134:584\u2013587","DOI":"10.1001\/archpedi.1980.02130180042013"},{"key":"2021120821081957100_R14","doi-asserted-by":"crossref","unstructured":"Lichtman SM, Attivissimo L, Goldman IS, Schuster MW, Buchbinder A. Secondary hemochromatosis as a long-term complication of the treatment of hematologic malignancies. Am J Hematol.1999;61:262\u2013264","DOI":"10.1002\/(SICI)1096-8652(199908)61:4<262::AID-AJH7>3.0.CO;2-B"},{"key":"2021120821081957100_R15","unstructured":"McKay PJ, Murphy JA, Cameron S, et al. Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation. Bone Marrow Transplant.1996;17:63\u201366"},{"key":"2021120821081957100_R16","doi-asserted-by":"crossref","unstructured":"Harrison P, Neilson JR, Marwah SS, Madden L, Bareford D, Milligan DW. Role of non-transferrin bound iron in iron overload and liver dysfunction in long term survivors of acute leukaemia and bone marrow transplantation. J Clin Pathol.1996;49:853\u2013856","DOI":"10.1136\/jcp.49.10.853"},{"key":"2021120821081957100_R17","doi-asserted-by":"crossref","unstructured":"Tomas JF, Pinilla I, Garcia-Buey ML, et al. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone Marrow Transplant.2000;26:649\u2013655","DOI":"10.1038\/sj.bmt.1702532"},{"key":"2021120821081957100_R18","doi-asserted-by":"crossref","unstructured":"Prati D. Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major. Vox Sang.2000;79:129\u2013137","DOI":"10.1046\/j.1423-0410.2000.7930129.x"},{"key":"2021120821081957100_R19","unstructured":"Comer GM, Ozick LA, Sachdev RK, at al. Transfusion-related chronic liver disease in sickle cell anemia. Am J Gastroenterol.1991;86:1232\u20131234"},{"key":"2021120821081957100_R20","unstructured":"Dallman PR. Changing iron needs from birth through adolescence. In: Fomon J, Zlotkin S, eds. Nutritional Anemias.1992:New York, NY: Raven Press;29\u201338"},{"key":"2021120821081957100_R21","doi-asserted-by":"crossref","unstructured":"Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood.1990;75:1870\u20131876","DOI":"10.1182\/blood.V75.9.1870.1870"},{"key":"2021120821081957100_R22","doi-asserted-by":"crossref","unstructured":"Punnonen K, Irjala K, Rajama\u0308ki A. Iron deficiency anemia is associated with high concentrations of transferrin receptor in serum. Clin Chem.1994;40:774\u2013776","DOI":"10.1093\/clinchem\/40.5.774"},{"key":"2021120821081957100_R23","doi-asserted-by":"crossref","unstructured":"Khumalo H, Gomo ZA, Moyo VM, et al. Serum transferrin receptors are decreased in the presence of iron overload. Clin Chem.1998;44;40\u201344","DOI":"10.1093\/clinchem\/44.1.40"},{"key":"2021120821081957100_R24","doi-asserted-by":"crossref","unstructured":"Gustafsson G, Kreuger A, Clausen N, et al. Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience f 2648 patients diagnosed between 1981 and 1996. Acta Paediatr.1998;87:1151\u20131161","DOI":"10.1111\/j.1651-2227.1998.tb00923.x"},{"key":"2021120821081957100_R25","doi-asserted-by":"crossref","unstructured":"Suominen P, Virtanen A, Lehtonen-Veromaa M, et al. Regression-based reference limits of serum transferrin receptor for children 6 months to 16 years of age. Clin Chem.2001;47:935\u2013937","DOI":"10.1093\/clinchem\/47.5.935"},{"key":"2021120821081957100_R26","doi-asserted-by":"crossref","unstructured":"Deugnier YM, Turlin B, Powell LW, et al. Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology.1993;17:30\u201334","DOI":"10.1002\/hep.1840170107"},{"key":"2021120821081957100_R27","unstructured":"Barton JC. Non-infectious transfusion reactions. In: Dutcher JP, ed. Modern Transfusion Therapy, I.1989:Cleveland, OH: CRC Press;57\u201392"},{"key":"2021120821081957100_R28","doi-asserted-by":"crossref","unstructured":"Schafer AI, Cheron RG, Dluhy R, et al. Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med.1981;304:319\u2013324","DOI":"10.1056\/NEJM198102053040603"},{"key":"2021120821081957100_R29","doi-asserted-by":"crossref","unstructured":"Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology.1986;6:24\u201329","DOI":"10.1002\/hep.1840060106"},{"key":"2021120821081957100_R30","doi-asserted-by":"crossref","unstructured":"Brissot P, Bourel M, Herry D, et al. Assessment of liver iron content of 271 patients: a reevaluation of direct and indirect methods. Gastroenterology.1981;80:557\u2013565","DOI":"10.1016\/0016-5085(81)90019-6"},{"key":"2021120821081957100_R31","doi-asserted-by":"crossref","unstructured":"Barton JC, Bertoli LF. Transfusion iron overload in adults with acute leukemia: manifestations and therapy. Am J Med Sci.2000;319:73\u201378","DOI":"10.1016\/S0002-9629(15)40691-3"},{"key":"2021120821081957100_R32","doi-asserted-by":"crossref","unstructured":"Brittenham GM, Cohen AR, McLaren CE, et al. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol.1993;42:81\u201385","DOI":"10.1002\/ajh.2830420116"},{"key":"2021120821081957100_R33","unstructured":"Mazza P, Giua R, De Marco S, et al. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of liver. Haematologica.1995;80:398\u2013404"},{"key":"2021120821081957100_R34","doi-asserted-by":"crossref","unstructured":"Harmatz P, Butensky E, Quirolo K, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood.2000;96:76\u201379","DOI":"10.1182\/blood.V96.1.76.013k22_76_79"},{"key":"2021120821081957100_R35","doi-asserted-by":"crossref","unstructured":"Birgegard G, Hallgren R, Killander A, Stromberg A, Venge P, Wide L. Serum ferritin during infection. A longitudinal study. Scand J Haematol.1978;21:333\u2013340","DOI":"10.1111\/j.1600-0609.1978.tb00374.x"},{"key":"2021120821081957100_R36","doi-asserted-by":"crossref","unstructured":"Siimes MA, Wang WC, Dallman PR. Elevated serum ferritin in children with malignancies. Scand J Haematol.1977;19:153\u2013158","DOI":"10.1111\/j.1600-0609.1977.tb02340.x"},{"key":"2021120821081957100_R37","doi-asserted-by":"crossref","unstructured":"Suominen P, Mo\u0308tto\u0308nen T, Rajama\u0308ki A, Irjala K. Single values of serum transferrin receptor and transferrin receptor-ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum.2000;43:1016\u20131020","DOI":"10.1002\/1529-0131(200005)43:5<1016::AID-ANR9>3.0.CO;2-3"},{"key":"2021120821081957100_R38","doi-asserted-by":"crossref","unstructured":"Suominen P, Punnonen K, Rajama\u0308ki A, Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood.1998;92:2934\u20132939","DOI":"10.1182\/blood.V92.8.2934"},{"key":"2021120821081957100_R39","doi-asserted-by":"crossref","unstructured":"Suominen P, Punnonen K, Rajama\u0308ki A, Irjala K. Evaluation of new immunoenzymometric assay for measuring soluble transferrin receptor to detect iron deficiency in anemic patients. Clin Chem.1997;43:1641\u20131646","DOI":"10.1093\/clinchem\/43.9.1641"},{"key":"2021120821081957100_R40","doi-asserted-by":"crossref","unstructured":"Tuomainen TP, Kontula K, Nyyssonen K, Lakka TA, Helio T, Salonen JT. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation. Circulation.1999;100:1274\u20131279","DOI":"10.1161\/01.CIR.100.12.1274"},{"key":"2021120821081957100_R41","doi-asserted-by":"crossref","unstructured":"Parkkila S, Niemela O, Savolainen ER, Koistinen P. HFE mutations do not account for transfusional iron overload in patients with acute myeloid leukemia. Transfusion.2001;41:828\u2013831","DOI":"10.1046\/j.1537-2995.2001.41060828.x"},{"key":"2021120821081957100_R42","doi-asserted-by":"crossref","unstructured":"Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology.1999;116:193\u2013207","DOI":"10.1016\/S0016-5085(99)70244-1"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/1\/91\/1006289\/pe0103000091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/111\/1\/91\/1006289\/pe0103000091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T01:08:02Z","timestamp":1639012082000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/111\/1\/91\/28490\/Iron-Overload-in-Children-Who-Are-Treated-for"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1,1]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,1,1]]},"published-print":{"date-parts":[[2003,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.111.1.91","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1,1]]}}}